Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3343307
Max Phase: Preclinical
Molecular Formula: C24H38N2O8
Molecular Weight: 482.57
Molecule Type: Small molecule
Associated Items:
ID: ALA3343307
Max Phase: Preclinical
Molecular Formula: C24H38N2O8
Molecular Weight: 482.57
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)N1CCC(C(=O)Nc2ccccc2OCCCO[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2O)CC1
Standard InChI: InChI=1S/C24H38N2O8/c1-15(2)26-10-8-16(9-11-26)23(30)25-17-6-3-4-7-18(17)32-12-5-13-33-22-21(29)20(28)19(14-27)34-24(22)31/h3-4,6-7,15-16,19-22,24,27-29,31H,5,8-14H2,1-2H3,(H,25,30)/t19-,20-,21+,22-,24-/m1/s1
Standard InChI Key: WHUQXGUMMKOMGZ-WKKMNAASSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 482.57 | Molecular Weight (Monoisotopic): 482.2628 | AlogP: 0.33 | #Rotatable Bonds: 10 |
Polar Surface Area: 140.95 | Molecular Species: BASE | HBA: 9 | HBD: 5 |
#RO5 Violations: 0 | HBA (Lipinski): 10 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.29 | CX Basic pKa: 14.83 | CX LogP: -0.21 | CX LogD: -2.11 |
Aromatic Rings: 1 | Heavy Atoms: 34 | QED Weighted: 0.30 | Np Likeness Score: -0.21 |
1. Belviso BD, Caliandro R, de Candia M, Zaetta G, Lopopolo G, Incampo F, Colucci M, Altomare CD.. (2014) How a β-D-glucoside side chain enhances binding affinity to thrombin of inhibitors bearing 2-chlorothiophene as P1 moiety: crystallography, fragment deconstruction study, and evaluation of antithrombotic properties., 57 (20): [PMID:25268757] [10.1021/jm5010754] |
Source(1):